Surgical treatment of symptomatic giant hemangiomas of the liver
- PMID: 1595024
Surgical treatment of symptomatic giant hemangiomas of the liver
Abstract
Cavernous hemangiomas are the most common benign tumors of the liver. Twenty-four patients who had hepatic resections for giant symptomatic hepatic hemangiomas during a six year period at a single institute were retrospectively reviewed to analyze indications for surgical treatment and evaluate operative mortality and morbidity. There were 18 women and six men varying in age from 41 to 69 years with an average age of 52.5 years. Moderate to severe pain, discomfort, feeling of fullness, bloating and sensation of an abdominal mass were the most commonly reported symptoms. Ten patients had moderate anemia and two had severe anemia. Tumors were visualized by ultrasonography in all patients and by computed tomography in 18. Angiography was performed in all patients with diagnostic confirmation of a benign hemangioma in all but one patient in whom an angiosarcoma was suspected. The resection was feasible in each patient: 20 minor hepatic resections (three wedge, 11 segmentectomies, six bisegmentectomies) and four right hepatic lobectomies were carried out. There were no surgical deaths. Two patients had postoperative complications: one patient had a pneumonia on the right side and one had wound infection. The benign nature of the tumors was confirmed in all. The lesions varied in size from 5.6 to 26 centimeters in diameter. Symptoms and hematologic disorders were relieved in all patients in the follow-up. The results of our experience confirm that resection for giant symptomatic hepatic hemangioma represents a safe radical curative procedure. Medical treatment is justified in smaller lesions or in asymptomatic patients.
Similar articles
-
[Cavernous hemangioma of the liver and hepatic hemangiomatosis. Indications and results of the surgical resection].Rev Gastroenterol Mex. 2003 Oct-Dec;68(4):277-82. Rev Gastroenterol Mex. 2003. PMID: 15125330 Spanish.
-
Hepatic resection for cavernous hemangiomas of the liver.Hiroshima J Med Sci. 1998 Dec;47(4):145-9. Hiroshima J Med Sci. 1998. PMID: 9973740
-
Surgical approach to symptomatic giant cavernous hemangioma of the liver.Hepatogastroenterology. 2005 Jan-Feb;52(61):183-6. Hepatogastroenterology. 2005. PMID: 15783025
-
Fetal and neonatal hepatic tumors.J Pediatr Surg. 2007 Nov;42(11):1797-803. doi: 10.1016/j.jpedsurg.2007.07.047. J Pediatr Surg. 2007. PMID: 18022426 Review.
-
Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma.J Gastrointest Surg. 2005 May-Jun;9(5):679-85. doi: 10.1016/j.gassur.2004.10.018. J Gastrointest Surg. 2005. PMID: 15862263 Review.
Cited by
-
Has laparoscopy increased surgical indications for benign tumors of the liver?Langenbecks Arch Surg. 2013 Feb;398(2):195-210. doi: 10.1007/s00423-012-1012-y. Epub 2012 Oct 9. Langenbecks Arch Surg. 2013. PMID: 23053460 Review.
-
Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma.PLoS One. 2015 Aug 19;10(8):e0135158. doi: 10.1371/journal.pone.0135158. eCollection 2015. PLoS One. 2015. PMID: 26287964 Free PMC article.
-
Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas.Hepatol Commun. 2024 Jan 11;8(1):e0359. doi: 10.1097/HC9.0000000000000359. eCollection 2024 Jan 1. Hepatol Commun. 2024. PMID: 38206210 Free PMC article.
-
Outcomes of surgery for giant hepatic hemangioma.BMC Surg. 2021 Apr 8;21(1):186. doi: 10.1186/s12893-021-01185-4. BMC Surg. 2021. PMID: 33832476 Free PMC article.
-
Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography.Int J Hepatol. 2013;2013:802180. doi: 10.1155/2013/802180. Epub 2013 May 16. Int J Hepatol. 2013. PMID: 23762570 Free PMC article.
MeSH terms
LinkOut - more resources
Medical